Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non–small cell lung cancer: the RECAPC multicenter registry

BackgroundMolecular profiling and programmed death-ligand 1 (PD-L1) status guide first-line treatment selection in metastatic non–small cell lung cancer, yet real-world testing, treatment delivery, and documentation vary across health systems. We described molecular testing documentation, first-line...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ricardo Brugés, Pedro Ramos, Milton Lombana, Anderson Osma, Néstor Llinás, Javier Cuello, Andrés Yepes, Ray Manneh, Anabelly Coronel, Rebeca Granadillo, Carolina López, Álvaro Osorio, Daniel Santa, Natalia Arango, William Mantilla, Diego Gómez
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-07-01
Sarja:	Frontiers in Oncology
Aiheet:	biomarkers non-small-cell lung cancer immunotherapy molecular targeted therapy neoplasm metastasis registries
Linkit:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1863940/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!